Prospettive e difficoltà della terapia cellulare in Cardiologia: Analisi critica delle sperimentazioni in corso

Translated title of the contribution: Current perspectives in cell therapy in Cardiology: An overview of ongoing trials

Paolo Scacciatella, Gianluca Amato, Elisa Ebrille, Mario Levis, Valeria Frisenda, Giulio Pompilio, Sebastiano Marra

Research output: Contribution to journalArticle

Abstract

Background. Cardiac cell therapy is still restricted to experimental studies and clinical trials. This investigation is an analytic overview of worldwide ongoing trials and is aimed to show useful findings for planning new clinical trials. Methods. Based on the online searching engine of the National Library of Medicine database for clinical trials (www.clinicaltrials.gov), all the ongoing studies registered were analyzed and classified. Results. On May 30, 2009, 95 studies were registered worldwide: 40 of these were conducted in Europe and 4 in Italy. Phase 1, 2, 3 and 4 studies were 28%, 57%, 14% and 1%, respectively; observational and randomized studies were 22% and 78%, respectively. The clinical setting of enrolled patients was acute coronary syndrome in 43 studies (46%), heart failure in 29 studies (30%), chronic heart disease in 23 studies (24%). The treatment strategies investigated are cytokine-induced cell mobilization in 8% and cell implantation in 92%. The cell types used for direct implantation are mononuclear cells in 81%, endothelial precursor cells CD34+ in 11%, endothelial precursor cells CD133 + in 5%, myoblasts in 2% and adipoblasts in 1% of cases. Conclusions. The present snapshot of worldwide ongoing clinical trials provides useful information for planning an experimental clinical program on cardiac cell therapy.

Original languageItalian
Pages (from-to)769-774
Number of pages6
JournalGiornale Italiano di Cardiologia
Volume11
Issue number10
Publication statusPublished - Oct 2010

Fingerprint

Cell- and Tissue-Based Therapy
Cardiology
Clinical Trials
Endothelial Cells
National Library of Medicine (U.S.)
Myoblasts
Acute Coronary Syndrome
Italy
Observational Studies
Heart Diseases
Chronic Disease
Heart Failure
Databases
Cytokines
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Scacciatella, P., Amato, G., Ebrille, E., Levis, M., Frisenda, V., Pompilio, G., & Marra, S. (2010). Prospettive e difficoltà della terapia cellulare in Cardiologia: Analisi critica delle sperimentazioni in corso. Giornale Italiano di Cardiologia, 11(10), 769-774.

Prospettive e difficoltà della terapia cellulare in Cardiologia : Analisi critica delle sperimentazioni in corso. / Scacciatella, Paolo; Amato, Gianluca; Ebrille, Elisa; Levis, Mario; Frisenda, Valeria; Pompilio, Giulio; Marra, Sebastiano.

In: Giornale Italiano di Cardiologia, Vol. 11, No. 10, 10.2010, p. 769-774.

Research output: Contribution to journalArticle

Scacciatella, P, Amato, G, Ebrille, E, Levis, M, Frisenda, V, Pompilio, G & Marra, S 2010, 'Prospettive e difficoltà della terapia cellulare in Cardiologia: Analisi critica delle sperimentazioni in corso', Giornale Italiano di Cardiologia, vol. 11, no. 10, pp. 769-774.
Scacciatella, Paolo ; Amato, Gianluca ; Ebrille, Elisa ; Levis, Mario ; Frisenda, Valeria ; Pompilio, Giulio ; Marra, Sebastiano. / Prospettive e difficoltà della terapia cellulare in Cardiologia : Analisi critica delle sperimentazioni in corso. In: Giornale Italiano di Cardiologia. 2010 ; Vol. 11, No. 10. pp. 769-774.
@article{63e21094f3474e98a61b8a7e28d7fa73,
title = "Prospettive e difficolt{\`a} della terapia cellulare in Cardiologia: Analisi critica delle sperimentazioni in corso",
abstract = "Background. Cardiac cell therapy is still restricted to experimental studies and clinical trials. This investigation is an analytic overview of worldwide ongoing trials and is aimed to show useful findings for planning new clinical trials. Methods. Based on the online searching engine of the National Library of Medicine database for clinical trials (www.clinicaltrials.gov), all the ongoing studies registered were analyzed and classified. Results. On May 30, 2009, 95 studies were registered worldwide: 40 of these were conducted in Europe and 4 in Italy. Phase 1, 2, 3 and 4 studies were 28{\%}, 57{\%}, 14{\%} and 1{\%}, respectively; observational and randomized studies were 22{\%} and 78{\%}, respectively. The clinical setting of enrolled patients was acute coronary syndrome in 43 studies (46{\%}), heart failure in 29 studies (30{\%}), chronic heart disease in 23 studies (24{\%}). The treatment strategies investigated are cytokine-induced cell mobilization in 8{\%} and cell implantation in 92{\%}. The cell types used for direct implantation are mononuclear cells in 81{\%}, endothelial precursor cells CD34+ in 11{\%}, endothelial precursor cells CD133 + in 5{\%}, myoblasts in 2{\%} and adipoblasts in 1{\%} of cases. Conclusions. The present snapshot of worldwide ongoing clinical trials provides useful information for planning an experimental clinical program on cardiac cell therapy.",
keywords = "Cardiovascular diseases, Clinical trials, Stem cells",
author = "Paolo Scacciatella and Gianluca Amato and Elisa Ebrille and Mario Levis and Valeria Frisenda and Giulio Pompilio and Sebastiano Marra",
year = "2010",
month = "10",
language = "Italian",
volume = "11",
pages = "769--774",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "10",

}

TY - JOUR

T1 - Prospettive e difficoltà della terapia cellulare in Cardiologia

T2 - Analisi critica delle sperimentazioni in corso

AU - Scacciatella, Paolo

AU - Amato, Gianluca

AU - Ebrille, Elisa

AU - Levis, Mario

AU - Frisenda, Valeria

AU - Pompilio, Giulio

AU - Marra, Sebastiano

PY - 2010/10

Y1 - 2010/10

N2 - Background. Cardiac cell therapy is still restricted to experimental studies and clinical trials. This investigation is an analytic overview of worldwide ongoing trials and is aimed to show useful findings for planning new clinical trials. Methods. Based on the online searching engine of the National Library of Medicine database for clinical trials (www.clinicaltrials.gov), all the ongoing studies registered were analyzed and classified. Results. On May 30, 2009, 95 studies were registered worldwide: 40 of these were conducted in Europe and 4 in Italy. Phase 1, 2, 3 and 4 studies were 28%, 57%, 14% and 1%, respectively; observational and randomized studies were 22% and 78%, respectively. The clinical setting of enrolled patients was acute coronary syndrome in 43 studies (46%), heart failure in 29 studies (30%), chronic heart disease in 23 studies (24%). The treatment strategies investigated are cytokine-induced cell mobilization in 8% and cell implantation in 92%. The cell types used for direct implantation are mononuclear cells in 81%, endothelial precursor cells CD34+ in 11%, endothelial precursor cells CD133 + in 5%, myoblasts in 2% and adipoblasts in 1% of cases. Conclusions. The present snapshot of worldwide ongoing clinical trials provides useful information for planning an experimental clinical program on cardiac cell therapy.

AB - Background. Cardiac cell therapy is still restricted to experimental studies and clinical trials. This investigation is an analytic overview of worldwide ongoing trials and is aimed to show useful findings for planning new clinical trials. Methods. Based on the online searching engine of the National Library of Medicine database for clinical trials (www.clinicaltrials.gov), all the ongoing studies registered were analyzed and classified. Results. On May 30, 2009, 95 studies were registered worldwide: 40 of these were conducted in Europe and 4 in Italy. Phase 1, 2, 3 and 4 studies were 28%, 57%, 14% and 1%, respectively; observational and randomized studies were 22% and 78%, respectively. The clinical setting of enrolled patients was acute coronary syndrome in 43 studies (46%), heart failure in 29 studies (30%), chronic heart disease in 23 studies (24%). The treatment strategies investigated are cytokine-induced cell mobilization in 8% and cell implantation in 92%. The cell types used for direct implantation are mononuclear cells in 81%, endothelial precursor cells CD34+ in 11%, endothelial precursor cells CD133 + in 5%, myoblasts in 2% and adipoblasts in 1% of cases. Conclusions. The present snapshot of worldwide ongoing clinical trials provides useful information for planning an experimental clinical program on cardiac cell therapy.

KW - Cardiovascular diseases

KW - Clinical trials

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=77957953642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957953642&partnerID=8YFLogxK

M3 - Articolo

C2 - 21246779

AN - SCOPUS:77957953642

VL - 11

SP - 769

EP - 774

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 10

ER -